Underwhelming Q1
Commenting on the results, Oppenheimer said the results are an ample evidence that the company continues to suffer mightily amid a shifting sector landscape. The firm noted the company reported earnings per share of $0.53, down 30 percent and below the consensus estimate of $0.66. Additionally, comps fell 2 percent, the firm said.
Analysts Brian Nagel and David Bellinger believe softer in-store sales and the ongoing margin weakness pressured results. The analysts noted that brick-and-mortar comps were down in mid-single digits, worse than the low-single-digit drop over the past several quarters, even as digital comps rose more than 20 percent.
The analysts also noted gross margins contracted 90 basis points to 36.5 percent compared to the consensus estimate of 36.8 percent.
The company maintained its 2017 earnings per share guidance for a low-single digit to a 10 percent drop, premised on flat to slightly positive comps and a lesser rate of gross margin contraction compared to a 70-basis-point contraction in 2016.
Lowering Estimates
Reflecting expectations for continued comp softness through year-end and the weak first-quarter results, Oppenheimer reduced its 2017 earnings per share estimate from $4.35 to $4.18 and its 2018 estimate from $4.30 to $4.12, with both estimates below the consensus estimates.
Oppenheimer said it remains optimistic that the company will successfully tweak its model, so as to compete more effectively in an omni-channel world. Though the pace of investment has stepped up, the firm indicated that clear signals of success are rare.
At the time of writing, shares of Bed Bath & Beyond were down 11.23 percent at $29.95.
Oppenheimer rates Bed Bath & Beyond a Perform with no specified 12–18-month price target.
Related Links:Retail Job Losses: Does This Point Toward Protracted Sectoral Weakness
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.